Significance of estimated glomerular filtration rate in predicting brain or heart attacks in obese and non-obese populations

Clinical and Experimental Nephrology

Volumn 19, Issue 5, 2015, Pages 790-796

  Sato, Yuji ^a   Fujimoto, Shouichi ^b   Konta, Tsuneo ^c   Iseki, Kunitoshi ^c   Moriyama, Toshiki ^c   Yamagata, Kunihiro ^c   Tsuruya, Kazuhiko ^c   Kimura, Kenjiro ^c   Narita, Ichiei ^c   Kondo, Masahide ^c   Asahi, Koichi ^c   Kurahashi, Issei ^d   Ohashi, Yasuo ^e   Watanabe, Tsuyoshi ^c  

^a UNIVERSITY OF MIYAZAKI HOSPITAL   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c Steering Committee for Design of the comprehensive health care system for chronic kidney disease (CKD) based on the individual risk assessment by Specific Health Checkups   (Japan)

^d IAnalysis LLC   (Japan)

^e CHUO UNIVERSITY   (Japan)

Author keywords

Body mass index; Cardiovascular disease; Cerebrovascular disease; Estimated GFR; Specific Health Checkup

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PROTEINURIA; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; CEREBROVASCULAR DISORDERS; COMPLICATION; HEALTH SURVEY; JAPAN; MYOCARDIAL INFARCTION; PREDICTIVE VALUE;

BODY MASS INDEX; CEREBROVASCULAR DISORDERS; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; HYPERTENSION; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PREDICTIVE VALUE OF TESTS; PROTEINURIA; RISK FACTORS;

EID: 84944168788     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-1062-2     Document Type: Article

References (16)

1. http://www.mhlw.go.jp/seisaku/2009/09/02.html (in Japanese).
2. Kohro T, Furui Y, Mitsutake N, Fujii R, Morita H, Oku S, et al. The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J. 2008;49(2):193–203.
3. Iseki K, Asahi K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, et al. Risk factor profiles based on estimated glomerular filtration rate and dipstick proteinuria among participants of the Specific Health Check and Guidance System in Japan 2008. Clin Exp Nephrol. 2012;16(2):244–9. doi:10.1007/s10157-011-0551-9.
4. Nagai K, Yamagata K, Ohkubo R, Saito C, Asahi K, Iseki K, et al. Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria. Nephrol Carlton. 2014;19(9):574–80. doi:10.1111/nep.12286.
5. Sato Y, Yano Y, Fujimoto S, Konta T, Iseki K, Moriyama T, et al. Glycohemoglobin not as predictive as fasting glucose as a measure of prediabetes in predicting proteinuria. Nephrol Dial Transplant. 2012;27:3862–8.
6. Yano Y, Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, et al. Association of high pulse pressure with proteinuria in subjects with diabetes, prediabetes, or normal glucose tolerance in a large Japanese general population sample. Diabetes Care. 2012;35(6):1310–5.
7. Konta T, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol. 2007;11(1):51–5.
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(Suppl 1):S62–9. doi:10.2337/dc11-S062.
9. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.
10. Stevens PE, Levin A. Kidney disease: improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30. doi:10.7326/0003-4819-158-11-201306040-00007.
11. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116(1):85–97. doi:10.1161/CIR.106.678342.
12. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24(1):29–33. doi:10.1161/01.ATV.0000099786.99623.EF.
13. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111(7):932–9. doi:10.1161/01.CIR.0000155620.10387.43.
14. Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(11):2276–83. doi:10.1161/ATVBAHA.107.147835.
15. Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R, et al. Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int. 2006;70(3):578–84. doi:10.1038/sj.ki.5001603.
16. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? meta-analysis. Diabetologia. 2009;52(4):691–7. doi:10.1007/s00125-009-1268-0.